Please login to the form below

Not currently logged in
Email:
Password:

Arrow

This page shows the latest Arrow news and features for those working in and with pharma, biotech and healthcare.

RET rivals Loxo and Blueprint face off with early-stage data

RET rivals Loxo and Blueprint face off with early-stage data

The ARROW trial revealed that 90% of patients with RET-altered medullary and papillary thyroid cancers had reduction in tumour volume overall, with a 62% response rate in medullary patients treated

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • The doctor will see you now? The doctor will see you now?

    As said initially, long waiting is not a matter of money, number of staff or size of arrows between squares in an organisation's chart.

  • Healthcare industry apps Healthcare industry apps

    Dr Trombino. Dr Trombino's arrows contain a direct thrombin inhibitor: fire them at the yellow factors to prevent the formation of blood clots!

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Dr David Chiswell joins Kymab Dr David Chiswell joins Kymab

    He brings over 30 years of biotechnology expertise to the firm, having held senior management positions at a number of pharmaceutical companies, including Arakis, Arrow Therapeutics, Daniolabs and Sosei.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Infographics